Michael J Davies Selected Research

Chronic Renal Insufficiency

4/2024	Time to clinical benefit with sotagliflozin in patients with type 2 diabetes and chronic kidney disease: Insights from the SCORED randomized trial.
1/2024	Sotagliflozin and Kidney Outcomes, Kidney Function, and Albuminuria in T2DM and CKD: A Secondary Analysis of the SCORED Trial.
11/2023	Effect of sotagliflozin on albuminuria in patients with type 2 diabetes and chronic kidney disease.
1/2023	Efficacy and safety of sotagliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease.
1/2022	Oxidant-mediated modification and cross-linking of beta-2-microglobulin.
7/2010	Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyperglycemic agents: analysis of a US electronic medical record database.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael J Davies Research Topics

Disease

60	Inflammation (Inflammations) 02/2024 - 01/2002
49	Type 2 Diabetes Mellitus (MODY) 04/2024 - 05/2005
42	Atherosclerosis 02/2024 - 04/2002
16	Hypoglycemia (Reactive Hypoglycemia) 01/2018 - 12/2005
11	Body Weight (Weight, Body) 01/2023 - 02/2008
10	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 05/2004
8	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2024 - 01/2013
8	Neoplasms (Cancer) 08/2023 - 01/2002
8	Hypertension (High Blood Pressure) 01/2018 - 08/2004
7	Atherosclerotic Plaque (Atheroma) 02/2023 - 03/2003
7	Asthma (Bronchial Asthma) 03/2011 - 04/2004
7	Coronary Disease (Coronary Heart Disease) 05/2006 - 10/2003
6	Chronic Renal Insufficiency 04/2024 - 07/2010
6	Infections 01/2021 - 10/2005
5	Cataract (Cataracts) 10/2016 - 07/2002
4	Heart Failure 11/2023 - 03/2015
4	Disease Progression 09/2023 - 11/2003
4	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 01/2021
4	Multiple Sclerosis 01/2023 - 01/2021
4	Rupture 01/2023 - 02/2002
3	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 03/2024 - 11/2020
3	Albuminuria 01/2024 - 01/2023
3	Stroke (Strokes) 01/2023 - 07/2004
3	Diarrhea 01/2023 - 08/2004
3	Necrosis 01/2021 - 09/2008
3	Fibrosis (Cirrhosis) 01/2021 - 01/2013
3	Insulin Resistance 01/2018 - 05/2002
3	Weight Loss (Weight Reduction) 01/2018 - 08/2002
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 07/2004
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2009 - 07/2005
3	Hyperlipidemias (Hyperlipidemia) 06/2008 - 04/2006
2	Kidney Diseases (Kidney Disease) 11/2023 - 01/2023
2	Atopic Dermatitis (Atopic Eczema) 07/2023 - 09/2021
2	Myocardial Infarction 01/2023 - 09/2008
2	Parkinson Disease (Parkinson's Disease) 01/2022 - 04/2002
2	Weight Gain 01/2021 - 07/2004
2	Reperfusion Injury 01/2021 - 12/2015
2	Overweight 01/2021 - 01/2018

Drug/Important Bio-Agent (IBA)

34	Proteins (Proteins, Gene)FDA Link 02/2024 - 04/2002
32	Oxidants (Oxidizing Agents)IBA 01/2023 - 11/2003
25	Peroxidase (Myeloperoxidase)IBA 08/2023 - 05/2009
20	Sitagliptin Phosphate (Januvia)FDA Link 01/2017 - 12/2005
17	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 05/2002
15	LipidsIBA 01/2017 - 04/2002
14	EnzymesIBA 08/2023 - 07/2002
14	Hypoglycemic Agents (Hypoglycemics)IBA 03/2015 - 11/2006
13	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 04/2024 - 11/2020
12	oxidized low density lipoproteinIBA 02/2023 - 04/2003
11	Insulin (Novolin)FDA Link 03/2024 - 05/2002
11	Peroxynitrous Acid (Peroxynitrite)IBA 01/2023 - 04/2007
10	Biomarkers (Surrogate Marker)IBA 02/2024 - 07/2008
10	SodiumIBA 01/2023 - 06/2016
9	SymportersIBA 01/2023 - 06/2016
8	Hypochlorous Acid (Hypochlorite)IBA 01/2021 - 09/2008
8	CanagliflozinIBA 01/2018 - 06/2016
8	Triglycerides (Triacylglycerol)IBA 01/2017 - 05/2002
8	hypobromous acidIBA 06/2013 - 10/2005
8	CholesterolIBA 01/2013 - 04/2002
7	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2023 - 06/2016
7	LDL Lipoproteins (beta Lipoproteins)IBA 02/2023 - 04/2002
7	Metformin (Glucophage)FDA LinkGeneric 01/2018 - 03/2009
7	IonsIBA 10/2016 - 05/2004
6	SeleniumIBA 01/2021 - 12/2011
6	LDL CholesterolIBA 01/2017 - 10/2003
6	Ezetimibe (Zetia)FDA Link 06/2008 - 07/2005
6	Simvastatin (Zocor)FDA LinkGeneric 02/2007 - 07/2004
5	thiocyanateIBA 01/2021 - 11/2011
4	Tyrosine (L-Tyrosine)FDA Link 01/2023 - 11/2004
4	Dimethyl FumarateIBA 01/2023 - 01/2021
4	CytokinesIBA 09/2021 - 02/2014
4	Heme (Haem)IBA 01/2021 - 05/2009
4	glimepiride (Amarel)FDA LinkGeneric 01/2018 - 06/2011
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 05/2011
4	MetalsIBA 10/2016 - 05/2004
4	Sulfhydryl Compounds (Thiols)IBA 12/2015 - 07/2009
4	Blood Proteins (Serum Proteins)IBA 11/2011 - 07/2005
4	GlycosaminoglycansIBA 08/2009 - 11/2003
3	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 01/2002
3	Fibronectins (Fibronectin)IBA 01/2023 - 01/2016
3	PeroxidasesIBA 01/2021 - 07/2008
3	CarnosineIBA 01/2019 - 03/2007
3	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2016 - 11/2004
3	Crystallins (Crystallin)IBA 10/2016 - 11/2004
3	CollagenIBA 09/2016 - 01/2013
3	Cholesterol Esters (Cholesteryl Esters)IBA 01/2011 - 09/2003
3	IncretinsIBA 04/2010 - 11/2006
3	Fenofibrate (CiL)FDA LinkGeneric 06/2008 - 04/2006
3	Dipeptidyl-Peptidase IV InhibitorsIBA 02/2008 - 01/2006
3	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2006 - 12/2005
2	Hemoglobins (Hemoglobin)IBA 11/2023 - 04/2013
2	1,4-anhydro-4-selenotalitolIBA 07/2023 - 09/2021
2	EpitopesIBA 02/2023 - 01/2023
2	Sodium-Glucose Transport ProteinsIBA 01/2023 - 01/2021
2	Acrolein (Aqualin)IBA 01/2023 - 01/2022
2	CreatinineIBA 01/2023 - 07/2010
2	Muramidase (Lysozyme)IBA 01/2021 - 11/2005
2	CalciumIBA 01/2021 - 06/2012

Therapy/Procedure

18	Therapeutics 01/2023 - 05/2004
9	Glycemic Control 01/2023 - 02/2008
3	Lenses 02/2014 - 11/2004